Scarica l'app Stockscreener
34.25
1.15%
-0.40
Dopo l'orario di chiusura:
35.40
1.15
+3.36%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRNX Giù?
Forum
Previsione
Precedente Chiudi:
$34.65
Aprire:
$34.59
Volume 24 ore:
1.32M
Relative Volume:
1.57
Capitalizzazione di mercato:
$3.23B
Reddito:
$4.72M
Utile/perdita netta:
$-277.91M
Rapporto P/E:
-9.1823
EPS:
-3.73
Flusso di cassa netto:
$-203.56M
1 W Prestazione:
+11.75%
1M Prestazione:
+21.37%
6M Prestazione:
+0.56%
1 anno Prestazione:
-35.13%
Intervallo 1D:
$33.40
$34.83
Intervallo di 1 settimana:
$30.25
$35.21
Portata 52W:
$24.10
$62.53
Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile
Nome
Crinetics Pharmaceuticals Inc
Settore
Industria
Telefono
858-450-6464
Indirizzo
6055 LUSK BLVD., SAN DIEGO, CA
Confronta CRNX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRNX
Crinetics Pharmaceuticals Inc
|
34.25 | 3.14B | 4.72M | -277.91M | -203.56M | -3.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Iniziato | Goldman | Neutral |
| 2025-03-25 | Iniziato | Stifel | Buy |
| 2025-02-11 | Iniziato | TD Cowen | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Peer Perform |
| 2025-01-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-06 | Iniziato | Citigroup | Buy |
| 2024-01-16 | Iniziato | Morgan Stanley | Overweight |
| 2023-12-21 | Iniziato | Jefferies | Hold |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2023-08-31 | Iniziato | Oppenheimer | Outperform |
| 2023-04-24 | Iniziato | Piper Sandler | Overweight |
| 2023-03-30 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-30 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-11-23 | Iniziato | Evercore ISI | Outperform |
| 2021-06-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-12-23 | Iniziato | ROTH Capital | Buy |
| 2019-02-14 | Iniziato | H.C. Wainwright | Buy |
| 2018-08-13 | Iniziato | JP Morgan | Neutral |
| 2018-08-13 | Iniziato | Leerink Partners | Outperform |
| 2018-08-13 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Crinetics Pharmaceuticals Inc Borsa (CRNX) Ultime notizie
Detecting price anomalies in Crinetics Pharmaceuticals Inc. with AIPortfolio Growth Summary & Community Verified Trade Signals - Newser
What machine learning models say about Crinetics Pharmaceuticals Inc.2025 Market WrapUp & Expert-Curated Trade Recommendations - Newser
Published on: 2025-09-03 08:54:39 - Newser
Crinetics: Low Expectations As The PDUFA Clock Ticks To Zero - Seeking Alpha
Crinetics Pharmaceuticals Soars 10.36% on Bullish Outlook - AInvest
Regression analysis insights on Crinetics Pharmaceuticals Inc. performanceQuarterly Profit Report & AI Based Buy/Sell Signal Reports - Newser
Technical analysis overview for Crinetics Pharmaceuticals Inc. stock2025 Investor Takeaways & Weekly High Momentum Picks - Newser
Using Ichimoku Cloud for Crinetics Pharmaceuticals Inc. technicals2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
How to build a custom watchlist for Crinetics Pharmaceuticals Inc.2025 Market Sentiment & Community Consensus Trade Alerts - Newser
Will Crinetics Pharmaceuticals Inc. stock recover after recent drop2025 Price Targets & Safe Entry Point Identification - Newser
Is Crinetics Pharmaceuticals Inc. stock reversal real or fakeMarket Risk Summary & Weekly High Potential Stock Alerts - Newser
What momentum shifts mean for Crinetics Pharmaceuticals Inc.Earnings Recap Report & AI Driven Stock Reports - Newser
Should you wait for a breakout in Crinetics Pharmaceuticals Inc.July 2025 Pullbacks & Capital Protection Trading Alerts - Newser
How to interpret RSI for Crinetics Pharmaceuticals Inc. stockFed Meeting & Risk Managed Investment Strategies - Newser
How to monitor Crinetics Pharmaceuticals Inc. with trend dashboardsGold Moves & AI Forecast for Swing Trade Picks - Newser
What’s the recovery path for long term holders of Crinetics Pharmaceuticals Inc.Weekly Risk Summary & Weekly High Potential Stock Alerts - Newser
Published on: 2025-09-02 06:24:06 - Newser
Combining price and volume data for Crinetics Pharmaceuticals Inc.CEO Change & Daily Stock Trend Reports - Newser
Is Crinetics Pharmaceuticals Inc.’s ROE strong enough2025 Price Momentum & Precise Entry and Exit Recommendations - khodrobank.com
Crinetics Pharmaceuticals Inc. stock trend forecastWall Street Watch & Risk Managed Trade Strategies - Newser
Is Crinetics Pharmaceuticals Inc. likely to announce a buybackWeekly Earnings Recap & Consistent Profit Trading Strategies - khodrobank.com
Will Crinetics Pharmaceuticals Inc. stock go up in YEARWeekly Market Outlook & Weekly Top Stock Performers List - khodrobank.com
Will Crinetics Pharmaceuticals Inc. benefit from seasonality2025 Market Overview & Community Trade Idea Sharing - khodrobank.com
Published on: 2025-09-01 15:42:21 - Newser
Should value investors consider Crinetics Pharmaceuticals Inc.Bond Market & Target Return Focused Picks - khodrobank.com
Building trade automation scripts for Crinetics Pharmaceuticals Inc.July 2025 Review & Real-Time Market Sentiment Alerts - Newser
How to forecast Crinetics Pharmaceuticals Inc. trends using time seriesForecast Cut & Real-Time Volume Spike Alerts - Newser
Statistical indicators supporting Crinetics Pharmaceuticals Inc.’s strengthGlobal Markets & Stepwise Trade Execution Plans - Newser
Crinetics Pharmaceuticals Inc. stock retracement – recovery analysisJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
Is Crinetics Pharmaceuticals Inc. reversing from oversold territoryMarket Activity Recap & Community Verified Watchlist Alerts - Newser
Crinetics Pharmaceuticals Inc. stock volume spike explainedMarket Performance Report & Daily Entry Point Alerts - Newser
Heatmap analysis for Crinetics Pharmaceuticals Inc. and competitorsLayoff News & Reliable Breakout Forecasts - Newser
Sentiment analysis tools applied to Crinetics Pharmaceuticals Inc.2025 Market Outlook & High Yield Stock Recommendations - Newser
Market Rankings: Fibonacci Levels Suggest Recovery for Crinetics Pharmaceuticals Inc.July 2025 Setups & Daily Profit Focused Stock Screening - beatles.ru
Will earnings trigger a reversal in Crinetics Pharmaceuticals Inc.Exit Point & Weekly Momentum Picks - Newser
Published on: 2025-08-30 23:56:26 - Newser
Can Crinetics Pharmaceuticals Inc. Outperform Peers After Recent Pullback getLinesFromResByArray error: size == 0 - 더경남뉴스
Crinetics Pharmaceuticals Inc Azioni (CRNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Crinetics Pharmaceuticals Inc Azioni (CRNX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Pizzuti Dana | Chief Med and Dev Officer |
Aug 22 '25 |
Option Exercise |
16.89 |
30,000 |
506,700 |
96,270 |
| Pizzuti Dana | Chief Med and Dev Officer |
Aug 22 '25 |
Sale |
30.43 |
30,000 |
912,900 |
66,270 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):